US Broker Ratings

AbbVie Inc. (ABBV) Stock Analysis: Strong Buy Ratings and Upside Potential Amidst Healthcare Innovations

AbbVie Inc. (NYSE: ABBV), a prominent player in the healthcare sector, stands out not only for its solid market cap of $406.87 billion but also for the compelling growth and..

Agilent Technologies, Inc. (A) Stock Analysis: Unlocking a 40% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector with a focus on diagnostics and research, presents an intriguing opportunity for investors. With a market capitalization of..

Novartis AG (NVS) Stock Analysis: Navigating Mixed Ratings and Dividend Appeal

Novartis AG (NYSE: NVS), a titan in the global healthcare sector, continues to draw investor attention with its robust pharmaceutical portfolio and strategic focus on innovation. Headquartered in Basel, Switzerland,..

Centene Corporation (CNC) Stock Analysis: Navigating a Complex Healthcare Landscape with a Promising 2.55% Upside

Centene Corporation (NYSE: CNC) stands as a formidable player in the healthcare sector, a key industry that continues to evolve amidst regulatory shifts and demographic changes. With a market capitalization..

Bristol-Myers Squibb (BMY) Stock Analysis: A Healthcare Giant with a Solid Dividend Yield and Strong ROE

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable presence in the healthcare sector, specifically within the drug manufacturing industry. With a market capitalization of $122.78 billion, Bristol-Myers Squibb has..

Veeva Systems Inc. (VEEV) Investor Outlook: Evaluating the 40.89% Potential Upside

Veeva Systems Inc. (NYSE: VEEV) stands as a formidable player in the healthcare sector, particularly in the specialized niche of health information services. Based in Pleasanton, California, Veeva Systems provides..

Intuitive Surgical, Inc. (ISRG): Investor Outlook with 24.41% Potential Upside

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leader in the healthcare sector specializing in medical instruments and supplies, is attracting interest from investors with its compelling growth potential and robust market..

UnitedHealth Group (UNH) Stock Report: Evaluating a 27% Upside Amidst Robust Revenue Growth

UnitedHealth Group Incorporated (NYSE: UNH) stands as a titan in the healthcare sector, with a commanding market capitalization of $260.03 billion. As a diversified healthcare company headquartered in Eden Prairie,..

Royalty Pharma plc (RPRX) Growth Potential: A Deep Dive into Analyst Ratings and Valuation Metrics

Royalty Pharma plc (NASDAQ: RPRX) has carved out a unique niche in the biotechnology sector by operating as a buyer of biopharmaceutical royalties and a funder of innovation. With a..

United Therapeutics Corporation (UTHR): Analyst Consensus Reveals 22% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR) is a prominent player in the healthcare sector, particularly in the specialty and generic drug manufacturing space. With a market capitalization of $20.96 billion, the..

AstraZeneca PLC (AZN) Stock Analysis: Evaluating Growth Potential with a 22.84% ROE

AstraZeneca PLC (AZN) remains a formidable player in the global healthcare sector, with its expansive portfolio of prescription medicines targeting a wide array of diseases. Based in Cambridge, UK, AstraZeneca..

Fresenius Medical Care AG (FMS) Stock Analysis: Uncovering an 18.45% Potential Upside Amidst Industry Challenges

Fresenius Medical Care AG (NYSE: FMS) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bad Homburg, Germany, the company is..

Zoetis Inc. (ZTS) Stock Analysis: A 24.35% Potential Upside in the Animal Health Sector

Investors looking for growth opportunities in the healthcare sector may want to take a closer look at Zoetis Inc. (NYSE: ZTS). As a leader in the animal health industry, Zoetis..

Cardinal Health, Inc. (CAH) Stock Analysis: A Healthcare Giant with 14.46% Potential Upside

Cardinal Health, Inc. (NYSE: CAH) stands as a formidable player in the healthcare sector, particularly within the medical distribution industry. With a robust market capitalization of $51.25 billion, the company..

STERIS plc (STE) Stock Analysis: 22% Potential Upside Amid Robust Revenue Growth

STERIS plc (NYSE: STE), a prominent player in the healthcare sector, is capturing investor attention with a promising potential upside of 22.01%. With a market capitalization of $22.62 billion, STERIS..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Biotech Powerhouse with 42% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading player in the biotechnology sector, continues to captivate investor interest with its innovative approach to therapeutics. This Cambridge, Massachusetts-based company specializes in the..

Medtronic plc (MDT) Stock Analysis: Exploring a 22.87% Upside Potential

Medtronic plc (MDT) stands as a formidable entity in the healthcare sector, specifically within the medical devices industry. Headquartered in Galway, Ireland, Medtronic boasts a market capitalization of $116.71 billion,..

Danaher Corporation (DHR) Stock Analysis: Unveiling a 35.50% Upside Potential Amidst Robust Analyst Support

For those keeping a close eye on the healthcare sector, Danaher Corporation (NYSE: DHR) represents a compelling investment option. With a market capitalization of $138.25 billion, Danaher is a heavyweight..

HCA Healthcare (HCA) Stock Analysis: Evaluating Growth in a Competitive Healthcare Sector

Investors eyeing the healthcare sector for stable and potentially lucrative opportunities may find HCA Healthcare, Inc. (NYSE: HCA) a compelling case study. With a market capitalization of $119.15 billion, HCA..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Analyst Consensus Points to a 35% Upside

For investors eyeing the healthcare sector, IQVIA Holdings, Inc. (NYSE: IQV) stands out as a formidable player within the diagnostics and research industry. Based in Durham, North Carolina, IQVIA offers..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds